HC Surgical Specialists Ltd(SG:1B1)
S$0.310.00 (0.00%)
SG:1B1
HC Surgical Specialists Ltd financials statements
S$0.31
At close:0.00 (0.00%)
Want to see SG:1B1 full AI Analyst Report?
HC Surgical Specialists Ltd (1B1) Ratios
5 Followers
HC Surgical Specialists Ltd Ratios
SG:1B1's free cash flow for Q1 2025 was S$1.72M. For the 2025 fiscal year, SG:1B1's free cash flow was decreased by S$-18.00K and operating cash flow was S$1.73M. See a summary of the company’s cash flow.
| Ratios | May 25 | May 24 | May 23 | May 22 | May 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.72 | 1.72 | 1.03 | 1.11 | 1.19 |
| Quick Ratio | 1.67 | 1.63 | 1.00 | 1.07 | 1.14 |
| Cash Ratio | 1.18 | 1.05 | 0.70 | 0.54 | 0.91 |
| Solvency Ratio | 0.75 | 1.59 | 0.42 | 0.24 | 0.41 |
| Operating Cash Flow Ratio | 1.18 | 1.49 | 0.60 | 0.63 | 0.92 |
| Short-Term Operating Cash Flow Coverage | 4.79 | 0.00 | 4.89 | 5.72 | 5.70 |
| Net Current Asset Value | S$ -609.00K | S$ 1.81M | S$ -2.49M | S$ -6.48M | S$ -10.62M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.10 | 0.16 | 0.18 | 0.20 |
| Debt-to-Equity Ratio | 0.13 | 0.13 | 0.30 | 0.45 | 0.57 |
| Debt-to-Capital Ratio | 0.11 | 0.12 | 0.23 | 0.31 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.10 | 0.19 |
| Financial Leverage Ratio | 1.56 | 1.30 | 1.90 | 2.58 | 2.81 |
| Debt Service Coverage Ratio | 3.53 | 42.24 | 3.29 | 2.58 | 5.06 |
| Interest Coverage Ratio | 41.79 | 27.54 | 14.08 | 12.75 | 18.14 |
| Debt to Market Cap | 0.03 | 0.00 | 0.03 | 0.04 | 0.05 |
| Interest Debt Per Share | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 |
| Net Debt to EBITDA | -0.77 | -0.21 | -0.43 | -0.12 | -0.07 |
| Profitability Margins | |||||
| Gross Profit Margin | 32.47% | 84.32% | 84.86% | 86.22% | 86.31% |
| EBIT Margin | 23.72% | 46.78% | 27.76% | 22.12% | 41.04% |
| EBITDA Margin | 34.03% | 56.92% | 37.28% | 31.26% | 49.68% |
| Operating Profit Margin | 23.72% | 37.05% | 37.43% | 42.52% | 44.51% |
| Pretax Profit Margin | 39.41% | 46.05% | 26.91% | 21.25% | 40.12% |
| Net Profit Margin | 36.04% | 44.16% | 20.45% | 15.30% | 33.04% |
| Continuous Operations Profit Margin | 37.11% | 45.94% | 20.94% | 15.65% | 35.23% |
| Net Income Per EBT | 91.45% | 95.90% | 75.99% | 72.02% | 82.35% |
| EBT Per EBIT | 166.13% | 124.31% | 71.88% | 49.97% | 90.12% |
| Return on Assets (ROA) | 21.45% | 30.94% | 13.81% | 9.34% | 20.61% |
| Return on Equity (ROE) | 33.41% | 40.28% | 26.18% | 24.12% | 58.00% |
| Return on Capital Employed (ROCE) | 17.71% | 31.57% | 40.69% | 40.89% | 36.87% |
| Return on Invested Capital (ROIC) | 15.69% | 29.65% | 27.71% | 26.97% | 29.57% |
| Return on Tangible Assets | 25.00% | 35.34% | 15.71% | 10.46% | 23.70% |
| Earnings Yield | 11.98% | 19.26% | 9.02% | 4.90% | 9.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.52 | 12.24 | 11.55 | 12.88 | 10.16 |
| Payables Turnover | 3.00 | 22.19 | 33.51 | 39.22 | 17.51 |
| Inventory Turnover | 35.28 | 7.15 | 7.76 | 5.91 | 7.03 |
| Fixed Asset Turnover | 5.68 | 5.10 | 4.73 | 4.24 | 4.98 |
| Asset Turnover | 0.60 | 0.70 | 0.68 | 0.61 | 0.62 |
| Working Capital Turnover Ratio | 4.70 | 10.01 | 23.31 | 13.89 | 4.71 |
| Cash Conversion Cycle | -62.78 | 64.42 | 67.73 | 80.84 | 66.99 |
| Days of Sales Outstanding | 48.55 | 29.82 | 31.59 | 28.34 | 35.93 |
| Days of Inventory Outstanding | 10.35 | 51.05 | 47.03 | 61.81 | 51.91 |
| Days of Payables Outstanding | 121.68 | 16.45 | 10.89 | 9.31 | 20.85 |
| Operating Cycle | 58.90 | 80.86 | 78.63 | 90.14 | 87.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 |
| Free Cash Flow Per Share | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 |
| Dividend Paid and CapEx Coverage Ratio | 2.37 | 2.59 | 2.35 | 1.81 | 1.23 |
| Capital Expenditure Coverage Ratio | 81.29 | 14.91 | 87.53 | 10.21 | 32.07 |
| Operating Cash Flow Coverage Ratio | 2.90 | 2.60 | 1.45 | 1.31 | 1.13 |
| Operating Cash Flow to Sales Ratio | 0.40 | 0.38 | 0.34 | 0.38 | 0.37 |
| Free Cash Flow Yield | 13.23% | 15.40% | 14.61% | 10.93% | 9.77% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 8.35 | 5.19 | 11.09 | 20.40 | 10.97 |
| Price-to-Sales (P/S) Ratio | 3.01 | 2.29 | 2.27 | 3.12 | 3.62 |
| Price-to-Book (P/B) Ratio | 2.79 | 2.09 | 2.90 | 4.92 | 6.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.56 | 6.49 | 6.84 | 9.15 | 10.24 |
| Price-to-Operating Cash Flow Ratio | 7.47 | 6.06 | 6.77 | 8.25 | 9.92 |
| Price-to-Earnings Growth (PEG) Ratio | -0.49 | 0.04 | 0.38 | -0.38 | -0.56 |
| Enterprise Value Multiple | 8.07 | 3.82 | 5.65 | 9.87 | 7.22 |
| Enterprise Value | 53.20M | 41.50M | 39.61M | 58.87M | 69.30M |
| EV to EBITDA | 8.07 | 3.82 | 5.65 | 9.87 | 7.22 |
| EV to Sales | 2.75 | 2.17 | 2.11 | 3.09 | 3.59 |
| EV to Free Cash Flow | 6.90 | 6.15 | 6.36 | 9.04 | 10.14 |
| EV to Operating Cash Flow | 6.82 | 5.74 | 6.29 | 8.16 | 9.82 |
| Tangible Book Value Per Share | 0.10 | 0.11 | 0.07 | 0.06 | 0.05 |
| Shareholders’ Equity Per Share | 0.14 | 0.14 | 0.10 | 0.08 | 0.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.06 | 0.00 | 0.22 | 0.26 | 0.12 |
| Revenue Per Share | 0.13 | 0.12 | 0.12 | 0.13 | 0.13 |
| Net Income Per Share | 0.05 | 0.05 | 0.03 | 0.02 | 0.04 |
| Tax Burden | 0.91 | 0.96 | 0.76 | 0.72 | 0.82 |
| Interest Burden | 1.66 | 0.98 | 0.97 | 0.96 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.09 | 0.02 | 0.02 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.12 | 0.82 | 1.25 | 1.78 | 0.91 |
Currency in SGD

